BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28678429)

  • 1. Global brain metabolic quantification with whole-head proton MRS at 3 T.
    Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
    NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
    Chen AM; Gerhalter T; Dehkharghani S; Peralta R; Gajdošík M; Gajdošík M; Tordjman M; Zabludovsky J; Sheriff S; Ahn S; Babb JS; Bushnik T; Zarate A; Silver JM; Im BS; Wall SP; Madelin G; Kirov II
    Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
    Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.
    Davitz MS; Wu WE; Soher BJ; Babb JS; Kirov II; Huang J; Fatterpekar G; Gonen O
    Magn Reson Imaging; 2017 Jan; 35():15-19. PubMed ID: 27580518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
    Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
    Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study.
    Kirov II; Tal A; Babb JS; Lui YW; Grossman RI; Gonen O
    J Neurol; 2013 Jan; 260(1):242-52. PubMed ID: 22886061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
    Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
    Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton MR spectroscopy of cerebellitis.
    Guerrini L; Belli G; Cellerini M; Nencini P; Mascalchi M
    Magn Reson Imaging; 2002 Oct; 20(8):619-22. PubMed ID: 12467871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
    Alkhalik Basha MA; Refaat R; Ahmed AF; Yousef HY; Alsowey AM; Metwally MI; Aly SA; Hussien HM; El-Saadany HF; AlGhobashy AA; Talat MA; Amer MM; Eid AM
    Eur J Radiol; 2019 Feb; 111():41-46. PubMed ID: 30691663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton MR spectroscopy of the brain in patients with congenital myotonic dystrophy].
    Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
    No To Hattatsu; 1995 May; 27(3):177-83. PubMed ID: 7662403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
    Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
    Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
    Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy of brain tumors.
    Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
    Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
    Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
    Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.